Media Pack
News

Current Edition

Volume 16 Issue 1
 
Regional News

Bluebird Bio has ‘doubts’ about continuing to do business through 2022, announces CFO resignation

With two of its prized gene therapies on clinical hold and another, Zynteglo, pulled from the market in Europe seven months ago after it was approved for use, these a...
9 March 2022 Regional News bio | Bluebird
Continue Reading →
Regional News

With the pricing situation ‘untenable’ in Europe, Bluebird will wind down its operations in the ‘broken’ market

Unable to reach a consensus with authorities in Europe around fair gene therapy pricing, bluebird bio will “wind down” its operations there to focus on business in th...
10 August 2021 Regional News Bluebird | manufacturing
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte